D
Pluri Inc. PLUR
$4.72 $0.11412.48%
Recommendation
Sell
Prev Close
$4.72
Volume
15,683
Avg Vol (90D)
19,579
Market Cap
$33.06M
Dividend & Yield
--
52-Week Range
$4.07 - $8.40
P/E (TTM)
--
EPS (TTM)
-$3.69
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Good
Efficiency Index
Very Weak
Solvency Index
Fair
Total Return Index
Weak
Volatility Index
Weak
Dividend Index
--
Headlines
Pluri announces exclusive collaboration agreement with Hemafund
3/5/2025 - The Fly
Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation ...
3/5/2025 - GuruFocus
Pluri Announces Exclusive Collaboration Agreement with Hemafund to Enhance Ukraine's Radiation Emergency Preparedness
3/5/2025 - Globe Newswire
Pluri (NASDAQ:PLUR) versus Kyverna Therapeutics (NASDAQ:KYTX) Head to Head Contrast
2/19/2025 - Ticker Report
Ever After Foods and B hler Collaborate to Scale Cultivated Meat Production and Distribution
2/19/2025 - Globe Newswire
Pluri Inc. Faces Financial Challenges Amid Continued Innovation
2/11/2025 - TipRanks Financial Blog
Pluri Ltd. Strengthens Financial Position Through Capital Raising
2/11/2025 - TipRanks Financial Blog
Pluri (NASDAQ:PLUR) Stock Price Down 4.4% - Should You Sell?
2/5/2025 - Ticker Report
Pluri secures additional $3.5 million investment
2/4/2025 - Seeking Alpha - Israel Stocks
Pluri secures additional $3.5 million investment
2/4/2025 - Seeking Alpha - Healthcare
Pluri secures additional $3.5M investment from Merchant Adventure Fund
2/4/2025 - TipRanks Financial Blog
Pluri secures additional $3.5M investment from Merchant Adventure Fund
2/4/2025 - The Fly
Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, ...
2/4/2025 - GuruFocus
Pluri Secures Additional $3.5 Million Investment from Major Shareholder at Premium to Market, Bringing Total Recent Financings to $10 Million
2/4/2025 - Globe Newswire
Pluri Strengthens Leadership Amid Strategic Board Appointment
1/29/2025 - TipRanks Financial Blog
Pluri gets $6.5M investment from Alejandro Weinstein, enters cacao market
1/23/2025 - The Fly
Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market ...
1/23/2025 - GuruFocus
Pluri secures $6.5M investment, acquires 71% stake in Kokomodo for $4.5M
1/23/2025 - The Fly
Pluri Secures $6.5 Million Strategic Investment at Premium to Market, Enters Cacao Market Through Acquisition
1/23/2025 - Globe Newswire
Head-To-Head Analysis: Pluri (NASDAQ:PLUR) vs. Anavex Life Sciences (NASDAQ:AVXL)
1/13/2025 - Ticker Report
Analyzing Pluri (NASDAQ:PLUR) and#038; Evaxion Biotech A/S (NASDAQ:EVAX)
12/31/2024 - Ticker Report
Pluri congratulates Mesoblast, CEO on FDA approval of MSC-based therapy
12/19/2024 - The Fly
Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for ...
12/19/2024 - GuruFocus
Pluri Congratulates Mesoblast on FDA Approval of First Mesenchymal Stromal Cell Therapy for Steroid-Refractory Acute Graft-Versus-Host Disease
12/19/2024 - Globe Newswire
Income Statement
Total Revenue (TTM)
$678.00K
EBITDA (TTM)
-$21.47M
EBIT (TTM)
-$21.72M
Net Income (TTM)
-$19.86M
Balance Sheet
Total Assets (Q)
$30.86M
Total Debt (Q)
$29.30M
Total Liabilities (Q)
$33.78M
Book Value Per Share (Q)
-$1.44
Cash Flow
Cash from Operations (TTM)
-$17.21M
Cash from Investing (TTM)
$10.09M
Cash from Financing (TTM)
$8.84M
Net Change in Cash (TTM)
$1.80M
Filings
Filing Date
Tuesday, February 11, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 5 and 9 (est)
Price History
Loading...
Beta
1.09
7-Day Total Return
0.09%
30-Day Total Return
4.98%
60-Day Total Return
3.71%
90-Day Total Return
3.60%
Year to Date Total Return
9.10%
1-Year Total Return
-37.51%
2-Year Total Return
-28.84%
3-Year Total Return
-71.61%
5-Year Total Return
-81.07%
52-week Low
Dec 31, 2024 - $4.07
52-week High
Mar 26, 2024 - $8.40
Valuation
Market Cap
$33.06M - Nano Cap
Enterprise Value
$46.15M
Price/Sales (TTM)
38.72
Price/Book (Q)
-3.27
Dividends and Shares
Shares Outstanding
5.55M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.pluri-biotech.com
Phone Number
972 74 710 8600
Address
Building No. 5
Haifa, 3508409
Country
Israel
Year Founded
2001
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Pluri Inc., a biotechnology company, engages in the research, development, and manufacture of cell-based products, cell therapeutics, and cell-based technologies for various industries. It... more
NASDAQ 03/17/2025 3:51PM Eastern Quotes delayed
Weiss Ratings